Atomistry » Chlorine » PDB 1zch-1zoh » 1zgv
Atomistry »
  Chlorine »
    PDB 1zch-1zoh »
      1zgv »

Chlorine in PDB 1zgv: Thrombin in Complex with An Oxazolopyridine Inhibitor 2

Enzymatic activity of Thrombin in Complex with An Oxazolopyridine Inhibitor 2

All present enzymatic activity of Thrombin in Complex with An Oxazolopyridine Inhibitor 2:
3.4.21.5;

Protein crystallography data

The structure of Thrombin in Complex with An Oxazolopyridine Inhibitor 2, PDB code: 1zgv was solved by J.Z.Deng, D.R.Mcmasters, P.M.Rabbat, P.D.Williams, C.A.Coburn, Y.Yan, L.C.Kuo, S.D.Lewis, B.J.Lucas, J.A.Krueger, B.Strulovici, J.P.Vacca, T.A.Lyle, C.S.Burgey, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 50.00 / 2.20
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 71.340, 72.330, 73.020, 90.00, 101.07, 90.00
R / Rfree (%) 19.7 / 22.8

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Thrombin in Complex with An Oxazolopyridine Inhibitor 2 (pdb code 1zgv). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Thrombin in Complex with An Oxazolopyridine Inhibitor 2, PDB code: 1zgv:

Chlorine binding site 1 out of 1 in 1zgv

Go back to Chlorine Binding Sites List in 1zgv
Chlorine binding site 1 out of 1 in the Thrombin in Complex with An Oxazolopyridine Inhibitor 2


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Thrombin in Complex with An Oxazolopyridine Inhibitor 2 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl1001

b:52.9
occ:1.00
CL41 A:5011001 0.0 52.9 1.0
C5 A:5011001 1.7 51.1 1.0
C4 A:5011001 2.7 50.7 1.0
C6 A:5011001 2.8 50.7 1.0
O A:TRP215 3.3 33.2 1.0
CA A:GLY226 3.5 25.6 1.0
N A:PHE227 3.5 21.3 1.0
O A:PHE227 3.6 19.3 1.0
CG1 A:VAL213 3.6 21.4 1.0
C A:GLY226 3.9 22.6 1.0
C A:TRP215 3.9 31.7 1.0
CZ A:TYR228 4.0 18.7 1.0
C3 A:5011001 4.0 50.9 1.0
CB A:ALA190 4.0 31.0 1.0
OH A:TYR228 4.1 22.4 1.0
C1 A:5011001 4.1 50.2 1.0
CE1 A:TYR228 4.2 21.6 1.0
N A:TRP215 4.2 27.3 1.0
C A:PHE227 4.3 19.9 1.0
N A:SER214 4.3 22.5 1.0
CE2 A:TYR228 4.3 18.1 1.0
O A:HOH1011 4.5 26.4 1.0
OD2 A:ASP189 4.5 31.9 1.0
CA A:TRP215 4.5 29.7 1.0
C2 A:5011001 4.5 50.7 1.0
CA A:PHE227 4.5 21.2 1.0
N A:GLY216 4.7 33.1 1.0
CA A:VAL213 4.7 20.9 1.0
CB A:VAL213 4.7 21.3 1.0
C A:SER214 4.8 26.2 1.0
CD1 A:TYR228 4.8 19.3 1.0
C A:VAL213 4.9 21.8 1.0
CD2 A:TYR228 4.9 18.0 1.0
O A:GLY226 4.9 21.9 1.0
CA A:GLY216 4.9 36.5 1.0
N A:GLY226 4.9 26.1 1.0

Reference:

J.Z.Deng, D.R.Mcmasters, P.M.Rabbat, P.D.Williams, C.A.Coburn, Y.Yan, L.C.Kuo, S.D.Lewis, B.J.Lucas, J.A.Krueger, B.Strulovici, J.P.Vacca, T.A.Lyle, C.S.Burgey. Development of An Oxazolopyridine Series of Dual Thrombin/Factor Xa Inhibitors Via Structure-Guided Lead Optimization. Bioorg.Med.Chem.Lett. V. 15 4411 2005.
ISSN: ISSN 0960-894X
PubMed: 16137886
DOI: 10.1016/J.BMCL.2005.07.022
Page generated: Sat Dec 12 08:56:57 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy